Tarsus Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Tarsus Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 25, 2026, with key proposals including director elections and executive compensation.
NASDAQ
Tarsus Pharmaceuticals will hold its annual stockholders meeting on June 12, 2025, to elect directors, vote on executive compensation, and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Tarsus Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 12, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
Tarsus Pharmaceuticals will hold its annual stockholders meeting on June 13, 2024, to vote on director re-elections and the ratification of its accounting firm.
NASDAQ
Tarsus Pharmaceuticals will hold its annual stockholders meeting virtually on June 13, 2024, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.